Glomerulonephritis, often accompanied by the nephrotic syndrome, developed in CAF1 mice following the administration of spleen cells from normal BALB/c mice. The renal lesion was membranous glomerulonephritis. When studied with fluorescein-conjugated antisera to either mouse gamma globulin or ß1C-globulin, the glomeruli contained beaded and irregular deposits of these immunoproteins. The ultrastructure of the lesion was characterized by thickening of the glomerular basement membranes and the presence of electron-dense subepithelial deposits. Acid eluates of the diseased kidneys contained gamma globulin that failed to bind to sections of normal kidneys. These findings conform to the type of nephritis provoked by immune complexes. They indicate that this type of immune injury can be based on the reaction of intolerant immunocytes to normal antigens.
Skip Nav Destination
Article navigation
1 October 1968
Article|
October 01 1968
CHRONIC ALLOGENEIC DISEASE : I. DEVELOPMENT OF GLOMERULONEPHRITIS
Robert M. Lewis,
Robert M. Lewis
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Martine Y. K. Armstrong,
Martine Y. K. Armstrong
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Janine André-Schwartz,
Janine André-Schwartz
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Asuman Muftuoglu,
Asuman Muftuoglu
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Lorraine Beldotti,
Lorraine Beldotti
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Robert S. Schwartz
Robert S. Schwartz
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Robert M. Lewis
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Martine Y. K. Armstrong
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Janine André-Schwartz
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Asuman Muftuoglu
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Lorraine Beldotti
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Robert S. Schwartz
From the Clinical Immunology Service, New England Medical Center Hospitals, the Department of Medicine, Tufts University School of Medicine, Boston 02111, and the Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts 02115
Received:
May 17 1968
Online ISSN: 1540-9538
Print ISSN: 0022-1007
Copyright © 1968 by The Rockefeller University Press
1968
J Exp Med (1968) 128 (4): 653–679.
Article history
Received:
May 17 1968
Citation
Robert M. Lewis, Martine Y. K. Armstrong, Janine André-Schwartz, Asuman Muftuoglu, Lorraine Beldotti, Robert S. Schwartz; CHRONIC ALLOGENEIC DISEASE : I. DEVELOPMENT OF GLOMERULONEPHRITIS . J Exp Med 1 October 1968; 128 (4): 653–679. doi: https://doi.org/10.1084/jem.128.4.653
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement